SCHEMBL4899747

SCHEMBL4899747

CCc1ccc(S(=O)(=O)NCCc2nc3cc(C)ccc3o2)cc1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.43
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
MAPT P10636 4/20 0.38
KDM4E B2RXH2 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 3/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
PTPN2 P17706 2/20 0.36
PTPN1 P18031 2/20 0.36
PTPN5 P54829 2/20 0.36
HSPD1 P10809 1/20 0.36
HSPE1 P61604 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906354 0.92 KDR (0.42) KDRALDH1A1RECQLMAPTKDM4E
SCHEMBL4895789 0.91 KDR (0.44) KDRNPC1RAB9AALDH1A1RECQL
SCHEMBL4899192 0.90 MEN1 (0.45) RXFP1MAPTTP53
SCHEMBL4895604 0.87 NPC1 (0.40) KDRNPC1RAB9AALDH1A1RECQL
SCHEMBL4902834 0.86 KDR (0.40) KDRNPC1RAB9ARXFP1ALDH1A1
SCHEMBL4897492 0.86 KDR (0.45) KDRRAB9AALDH1A1MAPTKDM4E
SCHEMBL4903825 0.83 LMNA (0.50) KDRALDH1A1KDM4ETP53POLB
SCHEMBL4902731 0.82 MEN1 (0.44) RECQLMAPTTP53LMNA
SCHEMBL4906063 0.81 LMNA (0.45) NPC1RAB9AALDH1A1RECQLMAPT
SCHEMBL4895325 0.81 NR1I2 (0.39) NPC1RAB9AALDH1A1MAPTPTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDR 1143/4885NPC1 59/4885RAB9A 2271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDR 1143/4885NPC1 59/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.